S 4332 · 119th Congress
Medication Competition Act
This bill requires the FDA to publicly list when biological drugs (like insulin, vaccines, and other complex medicines made from living cells) can have generic competitors. Right now, the FDA doesn't always clearly tell the public when these drugs' exclusive market periods end, which makes it harder for cheaper gene…
- Sponsor
- Hassan, Margaret Wood (D-New Hampshire)
- Introduced
- 2026-04-16
- Policy area
- Health
Digging through Congress... 🔍